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Abstract 
 
Rationale Caffeine is one of the psychoactive substances most widely used as adulterant 
in illicit drugs, such as cocaine. Animal studies have demonstrated that caffeine is able 
to potentiate several cocaine actions, although the enhancement of the cocaine 
reinforcing property by caffeine is less reported, and the results depend on the 
paradigms and experimental protocols used.  
Objectives We examined the ability of caffeine to enhance the motivational and 
rewarding properties of cocaine using the intravenous self-administration paradigm in 
rats. Additionally, the role of caffeine as a primer cue during extinction was evaluated.  
Methods In naïve rats was assessed: 1) the ability of the combination of cocaine (0.250 - 
0.125 mg/kg/infusion) and caffeine (0.125 - 0.0625 mg/kg/infusion) to maintain self-
administration in fixed ratio (FR) and progressive ratio (PR) schedules of reinforcement 
compared with cocaine or caffeine alone; 2) the effect of caffeine (0.0625 
mg/kg/infusion) in the maintenance of responding in the animals exposed to the 
combination of the drugs during cocaine extinction.  
Results The combination of cocaine and caffeine and cocaine alone were self-
administered on a FR and PR schedules of reinforcement. Interestingly, the breaking 
point determined for the cocaine and caffeine group was significantly higher than 
cocaine group. Moreover, caffeine, that per se did not maintain self-administration 
behavior in naïve rats, maintained drug-seeking behavior of rats previously exposed to 
combinations of cocaine and caffeine.  
Conclusions Caffeine enhances the reinforcing effects of cocaine and its motivational 
value. Our results highlight the role of active adulterants commonly used in cocaine-
based illicit street drugs.  
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Introduction 
 
 It is well known that illicit drugs of abuse are usually sold in the street with other 
substances in combination with the main psychoactive ingredient.  These substances 
could be adulterants, impurities or diluents. Adulterant refers to pharmacologically 
active ingredients while diluents refer to inert substances. Several forensic studies have 
reported that caffeine is one of the most common psychoactive adulterant found in illicit 
drugs of abuse (Cole et al. 2011) such as cocaine, either in its snorted (hydrochloride) or 
smoked forms (coca-paste or crack) (Evrard et al. 2010; López-Hill et al. 2011; Prieto et 
al. 2015). Caffeine is believed to be added to increase the weight and volume but also to 
mimic or potentiate the psychostimulant and reinforcing effects of cocaine. However, 
there are controversial data about caffeine action on the last property (Cole et al 2010). 
 Some authors consider caffeine as an atypical drug of dependence (Daly and 
Fredholm 1998) since it strictly fulfills some but not all of the DSM-V criteria for 
substance dependence. Actually, caffeine is a weak reinforcer and there is little evidence 
showing clinical dependence induced by its oral consumption (Nehlig and Boyet 2000; 
Strain and Griffiths 1995). Caffeine is commonly consumed on daily basis through 
different dietary sources like coffee, tea, cola and energy drinks. At low doses, caffeine 
can produce positive effects on arousal, vigilance and attention, usually devoid of severe 
consequences. However, after its chronic consumption and at high doses, symptoms of 
anxiety, nervousness, impaired thinking, sleep disturbance, heart palpitations and 
stomach irritation can emerge. Moreover, after a withdrawal period, mild symptoms like 
fatigue, headache, sleepiness, anxiety and irritability can also appear (Fisone et al. 2004; 
Fredholm et al. 1999; Nehlig 1999). In animal studies, it was demonstrated that caffeine 
is able to potentiate several effects of cocaine. For example, caffeine potentiates the 
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motor stimulation induced by cocaine (Misra et al. 1986; Lopez-Hill et al 2011; Prieto 
et al. 2012) or the expression of cocaine- or amphetamine-elicited sensitization (Cauli et 
al. 2003; Simola et al. 2006; Prieto et al. 2015). An additive reinforcement effect of 
caffeine with cocaine was observed in the conditioned place preference paradigm 
(Bedingfield et al. 1998). Moreover, caffeine pre-exposure has shown to accelerate the 
acquisition of cocaine self-administration (Horger et al. 1991) and to increase cocaine 
responding under a fixed ratio schedule (Schenk et al. 1994). Caffeine can also act as a 
primer for psychoactive drugs, producing the reinstatement of cocaine-taking behavior 
(Green and Schenk 2002; Schenk et al. 1996; Worley et al. 1994).  
The influence of caffeine on the abuse liability of other stimulants is also reported in 
clinical studies. In human laboratory studies, intravenous caffeine increased the rate of 
positive subjective effects in subjects with previous history of drug abuse of cocaine 
(Rush et al, 1995; Garrett and Griffiths, 2001). It has also been shown that caffeine 
administration potentiated nicotine effects (Jones and Griffiths, 2003; Perkins et al, 
1994). In addition, there is a growing consumption of high caffeinated products like 
energy drinks (Vester 2014), often in combination with other drugs (Reissig et al. 
2009). This evidence raises concerns about the role of caffeine in the development of 
dependence on other substances or relapse in former drug addicts. The combination 
with other stimulants and its potential toxicity leads to acute and long term adverse 
consequences (Derlet et al, 1992; McNamara et al, 2006; Camarasa et al, 2006) which 
may become aggravated by multiple factors, including the route of administration, 
chronicity, etc… (Johnson et al, 2010; Kuzmin et al, 2000). 
Given these premises, the purpose of this study was to further investigate the role of 
intravenous caffeine on the rewarding effect of cocaine and its motivational value in the 
rat. In this regard, we examined the ability of the combination of cocaine and caffeine to 
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maintain intravenous self-administration in rats under a fixed ratio and a progressive 
ratio schedule of reinforcement compared to cocaine alone. In addition, the role of 
caffeine as a primer cue during extinction was evaluated. Also, here we considered a 
doses ratio found in street samples of the drug of abuse (López Hill et al. 2011; Prieto et 
al. 2015). To our knowledge this is the first study that investigates the effect of caffeine 
on the rewarding properties of cocaine under a progressive ratio schedule of 
reinforcement and in a condition where caffeine is co-administered with cocaine. The 
results of this approach would help to further understand how the consume of caffeine 
in combination with other drugs may provoke changes in the abuse liability of these 
substances. 
 
Methods 
 
Subjects   
 
Male Sprague-Dawley rats (Harlan, Italy), weighing 225-250 g at the beginning of 
experimental procedures, were housed four per cage with ad libitum food and water, 
and with constant light–dark cycle (on 7:00 a.m., off 07:00 p.m.), temperature (22°C), 
and humidity (60%). After surgery, rats were individually housed in plastic cages with 
ad libitum food and water. For 7-10 days before surgery, rats were handled twice a day. 
Self-administration (SA) sessions were performed during the light phase, between 9:00 
a.m. and 5:00 p.m. After the experimental sessions, the rats were returned to their home 
cages, where a daily ration of 20 g of food was available. All procedures and 
experiments were carried out in an animal facility according to Italian (D.L. 116/92 and 
152/06) and European Council directives (609/86 and 63/2010) and in compliance with 
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the approved animal policies by the Ethical Committee for Animal Experiments (CESA, 
University of Cagliari) and the Italian Department of Health. All efforts have been made 
to minimize suffering and the numbers of animals used. 
 
Drugs and doses 
 
Cocaine hydrochloride (McFarlan, UK) and Caffeine (free base form, anhydrous, 
Tocris, UK) were dissolved in sterile saline (0.9 %). Both drugs were given 
intravenously in a volume of 24 μl per infusion. In order to evaluate the effect induced 
by caffeine as an active adulterant of cocaine, cocaine and caffeine doses of 0.25 or 
0.125 mg/kg, and 0.125 or 0.0625 mg/kg respectively were used. Cocaine doses were 
selected upon previous data (Valentini et al. 2013). Caffeine doses were selected to keep   
a similar dose ratio between the drugs found in coca-paste seized samples (López-Hill et 
al. 2011; Prieto et al. 2015) or in other street samples as reported in literature (see an 
overview at http://www.drugsandalcohol.ie/13119/).  
 
Catheter implant 
 
Rats were anaesthetized with Equitesin (0.97 g pentobarbital, 4.25 g chloral hydrate, 2.1 
g MgSO4, 42.8 ml propylene glycol, 11.5 ml 90 % ethanol/100 ml; 5 ml/kg i.p.) and 
implanted into the right jugular vein with a catheter (Medical-grade tubing; Silastic, 
Dow Corning Corporation, Midland, MI, USA) fixed in the middle scapular region by a 
polypropylene mesh (Evolution, BULEV, weight 48 g/mq, Dipromed, Italy). This 
ensured stable fixation, rapid tissue integration and reduced foreign body reaction. 
During recovery, catheters were daily flushed with 0.1 ml of enrofloxacin (50 mg/ml) 
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and heparinized saline (heparin 250 U/ml in 0.9 % sterile saline). One week after 
recovery from surgery, rats were randomly assigned to the following groups: a group 
trained to self-administer the combination of cocaine + caffeine (coc+caff), a second 
group trained to self-administer cocaine (coc) and a third group trained to self- 
administer caffeine (caff).  
 
Self-administration 
 
Daily SA sessions were carried out in sound proof boxes (Coulbourn Instruments, 
Allentown, NJ, USA), provided with two nosepoke holes, one active and the other 
inactive. A yellow/green light was placed over the active hole and a red light over the 
inactive one as discriminative stimuli. The responses performed by each rat on both 
holes (nose-pokes) and the corresponding number of reinforces received were recorded. 
Prior to each daily session, the jugular catheter was flushed with 0.1 ml of sterile saline, 
and the rats were placed in the SA box.  
Schedule Rats, according to the group they belonged to, were trained to self-administer 
coc+caff (0.25 + 0.125 mg/kg/24 µl), coc (0.25 mg/kg/24 µl) or caff (0.125 mg/kg/24 
µl) under a FR1 schedule for 15 daily sessions. By this time rats of coc+caff and coc 
groups had reached the criterion of 85 % responses on the active hole and were giving 
stable responses over the last three sessions. Thus, from the 16
th
 to the 20
th
 session 
doses of coc and caff were reduced by one-half (0.125 and 0.0625 mg/kg, respectively) 
under the same schedule FR1 for further 5 daily sessions. Thereafter, the schedule of 
reinforcing was switched to a progressive ratio (PR) for consecutive 7 daily sessions 
(days 21
st
-27
th
). In the PR sessions the work requirement (nose-poking) needed to 
receive a single i.v. drug infusion was progressively raised within each test session 
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according to the following  PR 3-4 series (meaning the 3
rd
 dose is reached with 4 
nosepokes): 1, 2, 4, 6, 9, 12, 15, 20, 25, 32, 40,  50, 62, 77, 95, 118, 145, 178, 219, 268, 
328, 402, 492 and 603 until the breaking point was reached (see details in Richardson & 
Roberts 1996). The breaking point was defined as the maximal work load (i.e. number 
of active nosepokes) completed for the last drug infusion prior to a 1-hour period during 
which no infusions were obtained by the animal. Maximal duration of a PR session was 
5 hr. After achieving 3 consecutive days of stable breaking points, each group of rats 
underwent to the extinction phase (from 28
th
 to the 38
th
 session). In the first phase of 
extinction (days 28
th
-34
th
) the group coc+caff was still allowed to self-administer 
caffeine alone (0.0625 mg/kg/24 µl) whereas coc group and caff group were shifted to 
inject saline. Subsequently, saline was substituted for caffeine also in coc+caff group 
for further 4 sessions (days 35
th
-38
th
). For each session, the number of nosepokes 
emitted (active and inactive), infusions, drug intake (cocaine and caffeine) and breaking 
points were calculated.  
 
Statistical analysis 
 
Statistical analysis was carried out by Statistica 6 (Stat Soft Inc, US).  
A total of 4 rats were excluded from the experiment due to catheter leakage during 
cocaine SA. The data recorded from these animals were excluded from analysis. 
Therefore the size of the analyzed and plotted data was derived from 12 rats for 
coc+caff group, 9 rats for coc group and 11 rats for caff group. Each phase of SA (FR1, 
PR3-4 and extinction) was assessed by independent analyses. 
Nose poking behavior during each daily cocaine SA session and during extinction was 
analyzed by three-way ANOVA, with group (coc+caff, coc and caff) and cumulative 
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nose-pokes (active vs inactive) as between-subject factors, and session as repeated mea- 
sure. Number of infusions and breaking point were analyzed by two-way ANOVA with 
repeated measures over sessions and group (ie, coc+caff, coc and caff) as between-
subject factor. Where significant effects were obtained, multiple pairwise contrasts by 
Tukey post hoc test were performed. Significance was set at P < 0.05.   
The between - groups effects on drug intake for each phase of SA and extinction 
(cocaine or caffeine) were analyzed with unpaired Student‟s t-test (P < 0.05). 
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Results 
 
Cocaine and caffeine intake during self-administration phases 
Table 1 shows the average amount of cocaine or caffeine earned during each phase of 
self-administration by coc+caff, coc and caff groups. Coc+caff and coc groups did not 
differ in cocaine intake under FR1 with cocaine 0.25 mg (P = 0.25) and cocaine 0.125 
mg (P = 0.19). Moreover, no differences within groups between the two doses of 
cocaine under FR1 were found (P > 0.05). On the other hand, cocaine intake under the 
PR was higher in coc+caff group than in coc group (P = 0.003). With regard to caffeine 
intake, analysis revealed that the amount of caffeine earned by coc+caff group was 
higher than caff group during both phases of FR1 (P < 0.001) as well as during the PR 
(P < 0.0001). Moreover, caff group significantly reduced caffeine intake when the dose 
was reduced by one half (0.0625 mg) under FR1 (P < 0.001).  
 
Cocaine and caffeine self-administration behavior  
Rats were trained to acquire self-administration of cocaine + caffeine (unit dose 0.25 
mg/kg and 0.125 mg/kg respectively, 5 day/week), cocaine alone (unit dose 0.25 mg/kg) 
or caffeine alone (unit dose 0.125 mg/kg) under FR 1 (1
st
-15
th
 session). From the 16
th
 
session the doses of cocaine and caffeine were reduced by one half. From the 21
th
 to the 
27
th
 session, the schedule of reinforcement FR1 was replaced with a PR schedule (PR 3-
4) followed by 11 session of extinction. The first 7 days of extinction (28
th
 – 34th 
session), coc+caff group received caffeine (unit dose 0.0625 mg/kg) whereas coc group 
and caff group were shifted directly to saline (24 μl/infusion). From the 35th session also 
coc+caff group received saline (24 μl/infusion). 
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Figure 1 shows cumulative active (panel A) and inactive (panel B) nosepokes performed 
by coc+caff, coc and caff groups throughout all the phases of SA and extinction. 
 
Cocaine and caffeine self-administration under a FR1 schedule of reinforcement. 
Analysis of data from FR1 phase (1
st
 – 20th session) by three-way ANOVA with group 
(coc+caff, coc and caff), nosepoke (active and inactive) and session as factors, showed a 
main effect of group (F2,58 = 15.62, P < 0.0001) nosepoke (F1,58 = 129.21, P < 0.0001) 
and session (F19,1102 = 17.14, P < 0.0001) and group x session (F38,1102 = 4.91, P < 
0.0001), group x nosepoke (F2,58 = 18.87, P < 0.0001) and group x nosepoke x session 
(F38,1102 = 4.75, P < 0.0001) interactions. The coc+caff rats acquired cocaine SA 
behavior under FR1 schedule from day 8 and, in order to maintain a stable cocaine 
intake (Table 1), they further increased active nose poking when the dose was reduced 
by one half under the same schedule (P < 0.05 for active nosepoke compared to 
inactive, and P < 0.05 for active nosepoke compared to session 15
th
, Tukey post-hoc 
test). Similarly, coc rats acquired cocaine SA behavior under FR1 schedule from day 10 
and further increased active nose poking when the dose was reduced by one half (P < 
0.05 for active nosepoke compared to inactive, and P < 0.05 for active nosepoke 
compared to session 15
th
, Tukey post-hoc test). Moreover, responding of both groups in 
the active nosepoke was significantly higher than caff group (P < 0.05, Tukey post-hoc 
test). On the other hand, rats from caff group did not show any consistent nose poking 
behavior at both doses of caffeine (0.125 and 0.0625 mg/kg) since the number of 
responding in the active nosepoke did not significantly differ from the inactive 
nosepoke (P > 0.05). 
 
Cocaine and caffeine self-administration under a PR schedule of reinforcement  
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Analysis of data obtained under the PR3-4 phase (21
st
 – 27th session) by three-way 
ANOVA revealed a main effect of group (F2,58 = 12.51, P < 0.0001) nosepoke (F1,58 = 
25.22, P < 0.0001) and session (F6,348 = 4.78, P < 0.0001) and group x session (F12,348 = 
2.02, P < 0.05), group x nosepoke (F2,58 = 10.01, P < 0.0001) and group x nosepoke x 
session (F12,348 = 3.05, P < 0.05) interactions. The coc+caff group showed a faster and 
higher active nose poking under PR schedule as compared to the coc group (P < 0.05 for 
coc+caff group active nosepoke compared to inactive, higher coc+caff group active 
nose poking compared to coc group from the 21
st
 to the 27
th
 session, P < 0.05 Tukey 
post-hoc test). Rats from caff group did not adjust their behavior according to the 
increased request of the PR schedule. As shown in the FR1 phase, also under PR 
schedule, responding of coc+caff and coc groups in the active nosepoke was 
significantly higher than caff group (P < 0.05, Tukey post-hoc test). 
 
Extinction of cocaine and caffeine self-administration under a FR1 schedule of 
reinforcement 
Three-way ANOVA of data obtained from extinction phase (28
th
 – 38th session) showed 
main effect of group (F2,56 = 18.83, P < 0.0001) nosepoke (F1,56 = 63.30, P < 0.0001) and 
session (F10,560 = 29.95, P < 0.0001) and group x session (F20,560 = 10.14, P < 0.0001), 
group x nosepoke (F2,56 = 14.61, P < 0.0001) and group x nosepoke x session (F20,560 = 
6.89, P < 0.0001) interactions. 
During extinction, rats from coc+caff group (that received caffeine for the first 7 
sessions) extinguished SA behavior slower than coc group with a reduction of active 
nose poking only during the last 4 days when caffeine was substituted with saline (P < 
0.05 for coc+caff group active nosepoke compared to inactive from the 28
th
 to the 34
th
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session, higher coc+caff group active nose poking compared to coc group from 28
th
 to 
the 32
nd
 session, P < 0.05 Tukey post-hoc test). 
In coc group, substitution of cocaine with saline resulted in a marked fall of responding 
on the active hole after the third saline session (P < 0.05 active nosepoke compared to 
inactive from the 28
th
 to the 30
th
 session, Tukey post-hoc test). Both coc+caff and coc 
group showed a higher active nose poking behavior than caff group (P < 0.05 Tukey 
post-hoc test).  
 
Figure 2 shows the pattern of responding for a typical rat from each of the groups 
(coc+caff, coc and caff) at different sessions of FR1, PR and extinction.  Both coc+caff 
and coc groups showed highly regular response patterns under the FR1 schedule of 
reinforcement (sessions 12 and 16). When animals were shifted to PR 3-4 schedule, the 
coc+caff group displayed a strong burst of responding and a longer lasting response rate 
than coc group; with both groups selectively increasing responding on the active 
nosepoke (session 26). During the early phase of extinction, coc+caff group still 
maintained a regular overall response pattern, whereas in coc group responding was 
progressively reduced and erratic (sessions 28-34). Later, responding patterns became 
erratic also for coc+caff group, indicative of a full extinction of SA behavior. On the 
other hand, the response patterns of caff group were low and erratic throughout all the 
sessions. 
 
 
Cocaine and caffeine infusion during the self-administration behavior  
Figure 3 shows the number of infusions earned by rats of each group (coc+caff, coc and 
caff) throughout all the phases of SA and extinction.  
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Analysis of data from FR1 phase (1
st
 – 20th session) by two-way ANOVA with group 
(coc+caff, coc and caff) and session as factors, showed a main effect of group (F2,29 = 
25.86, P < 0.0001) and session (F19,551 = 43.26, P < 0.0001) and group x session 
interaction (F38, 551 = 10.38, P < 0.001). 
In the coc+caff group, the number of infusion was higher respect to caff group from day 
8 and further increased when the dose was reduced by one half under the same schedule 
(P < 0.05 for coc+caff group compared to caff group, and P < 0.05 for coc+caff group 
infusion compared to session 15
th
, Tukey post-hoc test). Similarly, in coc rats the 
number of infusion was significantly higher compared to caff group from day 10 and 
further increased when the dose was reduced by one half (P < 0.05 for coc group 
compared to caff group, and P < 0.05 for coc group infusion compared to session 15
th
, 
Tukey post-hoc test). Moreover, during FR1 no difference in the number of infusions 
was found between coc+caff and coc groups rats (P > 0.05). 
Analysis of data obtained from PR phase (21
st
 – 27th session) by two-way ANOVA 
showed a main effect of group (F2,29 = 48.16, P < 0.0001) and session (F6,174 = 4.02, P < 
0.0001) and group x session interaction (F12, 174 = 3.66, P < 0.001). Tukey post-hoc test 
revealed that the number of infusion was significantly higher in coc+caff group 
compared to coc group and caff group (P < 0.05). On the other hand, the number of 
infusion earned by coc group was higher than caff group as well (P < 0.05). 
Two-way ANOVA of data obtained from extinction phase (28
th
 – 38th session) showed 
main effect of group (F2,27 = 19.62, P < 0.0001) and session (F10,270 = 17.00, P < 0.0001) 
and group x session interaction (F20,270 = 6.93, P < 0.001). During extinction the number 
of infusions earned by coc+caff remained higher and decreased more slowly compared 
to coc group (P < 0.05, Tukey post-hoc). Moreover, the number of infusions earned by 
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coc+caff group and coc group was significantly higher than caff group (P < 0.05, Tukey 
post-hoc). 
 
Breaking point 
Behavior during the PR3-4 phase was also evaluated as the response requirement of the 
final ratio completed (breaking point, Fig. 4). Analysis of the results by Two-way 
ANOVA revealed a main effect of group (F2,29 = 18.77, P < 0.0001) and session (F6,174 = 
6.77, P < 0.0001) and group x session interaction (F12,174 = 2.70, P = 0.002). The 
breaking point of coc+caff group was consistently higher compared to coc group over 
the sessions (P < 0.05, Tukey post-hoc test). Moreover, the breaking point of coc+caff 
and coc groups was higher than caff group from the 21
st
 and 24
th
 session, respectively 
(P < 0.05, Tukey post-hoc test).  
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Discussion 
 
 The aim of this work was to investigate the role of caffeine in the reinforcement 
and particularly in motivational and rewarding properties of cocaine. To our knowledge, 
this is the first time that the effect of the combination of caffeine and cocaine was 
investigated in a self-administration paradigm with different schedules of reinforcement 
(FR and PR) and extinction. Another important aspect is the route of administration 
used for caffeine (intravenously administered) and the dose ratio of the combination of 
cocaine and caffeine (2:1) comparable to that found in illicit sample from the street. 
 In our study, we found that during the acquisition of the self-administration 
behavior on a FR1 schedule, caffeine did not affect the response for cocaine. In fact, rats 
exposed to self-administer the combination of cocaine and caffeine acquired and 
maintained the self-administration behavior similarly to rats administering cocaine 
alone. As expected, caffeine alone did not induce a self-administration behavior, 
showing no significant difference between the number of active and inactive nosepokes 
in any of the protocol phases. This last finding is not surprising and confirms previous 
data from the literature being the primary reinforcing effect of caffeine difficult to 
measure in animals (Atkinson and Enslen, 1976; Hoffmeister and Wuttke, 1973; Myers 
and Izbicki, 2006).  
Interestingly our results show that caffeine was able to potentiate cocaine self-
administration behavior on a PR schedule of reinforcement. Under this phase, rats of the 
coc+caff group significantly increased their responding on the active nosepoke, the 
number of infusions and the breaking point compared to coc group. These effects 
suggest that caffeine has a significant action on motivational properties of cocaine.  
 Another important finding is that caffeine prolonged the extinction of 
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responding in animals with a previous history of combination with cocaine. In the 
extinction phase, in fact, the only presence of caffeine maintained a higher level of 
responding in rats that previously administered the combination of cocaine and caffeine 
compared to the coc group. A putative primary reinforcing effect of caffeine is unlikely. 
Very few studies have shown a role of caffeine as a primary reinforcer but only under 
particular conditions, at low doses and with limited or intermittent exposures (Myers 
and Izbicky, 2006; Simola et al, 2006; Sheppard et al, 2012; Retzbach et al, 2014). In 
our hands, the capacity of caffeine to maintain a high drug-seeking behavior during 
extinction suggests that it may serve as a primer of cocaine-related reward circuitry. 
Thus, caffeine doesn‟t have reinforcing properties itself, but enhancing the rewarding 
properties of cocaine, behaves as an effective discriminative stimulus for maintaining 
the drug-seeking behavior in animals.  
One major limitation of the present study is the lack of some control groups that would 
address different issues. In particular, it would have been interesting to study the 
behavior under the extinction with saline of rats that previously experienced the 
combination of cocaine and caffeine or vice-versa the effect of caffeine in those animals 
that previously experienced cocaine alone. Previous data from the literature showed, in 
the first day of extinction, a higher number of responding in the lever previously 
associated to cocaine after acute caffeine exposure compared to saline. Also caffeine 
was able to reinstate extinguished cocaine taking-behavior but this effect was reduced 
by repeated exposure to caffeine (Worley et al, 1994; Schenk et al, 1996). 
On the other hand, it is tempting to speculate that rats previously exposed to the 
combination of cocaine and caffeine would even display a higher and longer lasting 
seeking behavior than coc group based on the evidence (present study) that rats of 
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coc+caff group under a PR schedule showed a higher rate of responding for cocaine and 
a greater breaking point compared to rats of coc group. This effect would reflect the 
expression of the greater craving for cocaine in rats in which repeated exposure to 
caffeine increased the rewarding and motivational properties of the drug.  
However, additional studies should be carried out to verify this hypothesis. 
 The present results not only agree with previous observations but expand the 
view that caffeine may behave as a potent reinforcement enhancer. More specifically, in 
animals, caffeine can amplify cocaine-mediated (Harland et al. 1989; Holloway et al. 
1985) and nicotine-mediated discriminative effects (Gasior et al. 2000; 2002), increase 
operant responding for cocaine (Kuzmin et al. 2000; Schenk et al. 1994), nicotine 
(Shoaib et al. 1999), alcohol drinking (Kunin et al. 2000) and reinstate cocaine seeking 
behavior (Green and Schenk, 2002; Regier et al, 2014; Worley et al. 1994). In human 
laboratory studies, intravenous caffeine increases the rate of positive subjective effects 
in subjects with previous history of drug abuse of cocaine (Rush et al, 1995; Garrett and 
Griffiths, 2001). Also, recent studies extended this effect of caffeine to non-drug 
reinforcement (Sheppard et al. 2012).  
 One possible explanation for the ability of caffeine to increase responding for 
cocaine could be related to its psychomotor stimulant properties. Exposure to caffeine 
increases the psychomotor stimulants effects of amphetamine (Cauli et al. 2003; 
Palmatier et al. 2003; Simola et al. 2006), nicotine (Celik et al. 2006; Gasior et al. 2000) 
and cocaine (López-Hill et al 2011; Misra et al. 1986; Prieto et al. 2015).  However, this 
effect doesn‟t explain our results since the increase in responding of coc+caff group was 
restricted to the active nosepoke, whereas inactive nosepoke responding remained low 
all times. Therefore, the ability of caffeine to enhance responding for cocaine on the PR 
schedule and maintain cocaine seeking behavior on extinction phase cannot be easily 
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attributed to its motor activating effects. It is more likely that caffeine, when chronically 
administered with cocaine, becomes a potent discriminative stimulus, enhancing the 
rewarding properties of cocaine. Caffeine is a psychomotor stimulant and, particularly 
when administered in low doses, produces many of its behavioral effects via adenosine 
A1 and A2 receptors blockade, influencing indirectly dopaminergic system (Ferr  and 
Fuxe, 1992; Garrett and Griffiths, 1997).  
On the other hand, cocaine blocks the dopamine (DA) transporter in the plasma 
membrane of striatal DA nerve terminal networks. This mechanism leads to a marked 
increase of DA transmission and is thought to underlie the rewarding/reinforcing actions 
of cocaine in humans that lead to drug abuse and addiction (Di Chiara and Imperato, 
1988; Kalivas and Volkow, 2005; Koob and Bloom, 1988). On this basis, some author 
reported that caffeine increased DA in the NAc shell (Solinas et al. 2002) suggesting 
that it might amplify cocaine mediated effects by facilitating dopamine transmission 
(Green and Schenk, 2002). However, this effect was only obtained after high doses of 
caffeine and it could not be corroborated by other authors. Acquas et al. (2002) and De 
Luca et al. (2007) showed that caffeine did not increase DA in the NAc shell and 
recently this evidence has been extended to humans (Volkow et al. 2015). Thus 
caffeine, rather than by increasing DA in the striatum, might enhance post-synaptic DA 
signaling by increasing D2R levels and/or their affinity (Volkow et al. 2015). It is more 
likely that caffeine, by its antagonism of A2AR in striatal pathways, would facilitate the 
adenylate cyclase inhibition induced by DA D2 activation (Ferré, 2008). More recently 
the same author highlighted the role of the striatal A2A-D2 receptor heteromer as the 
main target of caffeine by which caffeine potentiates the acute and long-term effects of 
prototypical psychostimulants (Ferré, 2016). 
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 Several data from literature support this evidence. It has been shown that 
stimulation of A1AR and A2AR reduces numerous cocaine-related behaviors through 
their ability to functionally oppose selective dopamine receptor activity (Hack and 
Christie 2003). The stimulation of A1ARs or A2ARs blocks the expression of cocaine 
sensitization (Filip et al. 2006; Hobson et al. 2012) and impairs the expression of 
cocaine-conditioned place preference (Poleszak and Malec 2002). On the other hand, 
antagonism of either A1AR or A2AR substitutes for cocaine and produces leftward 
shifts in cocaine discrimination (Justinova et al. 2003). In a self-administration 
paradigm, A2AR stimulation attenuates acquisition of cocaine self-administration 
(Knapp et al. 2001), whereas antagonism of A2AR enhances responding for cocaine on 
a progressive ratio schedule of reinforcement without effect on fixed ratio responding 
(Doyle et al. 2012; Justinova et al. 2011). Furthermore, stimulation of A2A receptors 
diminishes brain stimulation reward, whereas blocking adenosine receptors reverses the 
reward impairment produced by cocaine withdrawal or by an A2A agonist (Baldo et al. 
1999). Finally, stimulation of A1ARs and A2ARs suppresses cocaine reinstatement, 
while blockade of A2AR enhances cocaine seeking behavior (Bachtell and Self, 2009; 
Hobson et al. 2013; O'Neill et al. 2012; O'Neill et al. 2014).  
Moreover, besides acting on adenosine receptors, caffeine interacts with PDE, MAO, 
AChE, ryanodine receptors and others (Pohanka 2015). Thus, interaction with some of 
these pathways may also account for a direct or indirect potentiation of cocaine effects. 
However, there is no evidence on metabolic interactions between cocaine and caffeine. 
Schenk et al (1994) excluded pharmacokinetic alteration of cocaine by caffeine since 
they found a more pronounced effect of caffeine with low and sub-threshold doses.  
 In conclusion, the present findings extend the knowledge on the role of caffeine 
as a potent enhancer of the reinforcing effects of cocaine and the motivational value of 
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the drug. Several human and animal studies have investigated the interaction of caffeine 
with nicotine and alcohol, but the literature regarding the interaction of caffeine with 
other drugs of abuse (e.g. cocaine and heroin) is still meager. These findings are 
relevant for the important implications that these motivational effects may have in 
humans. Caffeine is an important ingredient of energy drinks and one of the worldwide 
adulterant intentionally added to illicit drugs to enhance or mimic their primary effects, 
particularly to cocaine, in snorted or any of its smoked forms, and heroin (see Cole et al. 
2010 for review). Thus, the combination of caffeine with other drugs may increase the 
motivation to consume the drug (Kozlowsky et al, 1993; Strain et al, 1994; Swanson et 
al, 1994; Marczinski 2014) with important implications for public health, as individuals 
tend to engage in more risky behaviors (Jones and Lejuez 2005; Martin et al, 2008). In 
addition, the present findings give a hint for further studies and are important in terms 
of their translational potential. In fact, besides the adverse effects that adulterants, and in 
particular caffeine, have in term of increased toxicity of the adulterated- compared to 
the unadulterated-drug (Vanattou-Saifoudine et al, 2012), this study highlight the 
additional concern to the public health of an increased potentiality of abuse.  
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  FR1 (1st-15th sess) 
Cocaine             Caffeine 
FR1 (16th -20th sess) 
Cocaine            Caffeine 
PR 3-4 
Cocaine            Caffeine 
 
Group         
coc+caff  4.9±0.6 2.5±0.3# 6.2±0.4 3.1±0.2# 1.9±0.1* 0.9±0.05#  
         
coc  3.9±0.5 ------ 5.0±0.8     ------ 1.3±0.1     ------  
         
caff     ------ 1.0±0.1 ------ 0.6±0.1§     ------ 0.2±0.02  
 
Table 1 Average amount (mg/kg, mean ± SEM) of cocaine and caffeine earned 
during each phase of self-administration by coc+caff, coc and caff groups.  
* P < 0.05 vs. coc group; # P < 0.05 vs. caff group; § P < 0.05 vs. FR1 (1
st
-15
th
 
sess).   
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Figure 1 
 
Fig. 1 Cumulative responses during cocaine/caffeine self-administration and extinction 
(1
st–38th session). Results are expressed as mean±SEM of cumulative nosepokes in the 
active (A) and inactive (B) holes of each group (coc+caff; coc and caff). Filled symbol 
denotes P < 0.05 vs inactive nosepokes; # P < 0.05 coc+caff group vs the corresponding 
active nosepokes of caff group; + P < 0.05 coc group vs the corresponding active 
nosepokes of caff group; ° P < 0.05 coc+caff group vs the corresponding active 
nosepokes of the 15
th SA session; ^ P < 0.05 coc group vs the corresponding active 
nosepokes of the 15
th SA session; * P < 0.05 coc+caff group vs the corresponding active 
nosepokes of coc group. 
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Figure 2 
 
 
Figure 2 Individual representative records illustrating responding patterns of coc+caff 
(top trace), coc (middle trace) and caff (bottom trace) rats at the active (upward ticks) 
and inactive (downward ticks) nosepoke in the sessions throughout the phases of the 
study. Each tick denotes the time of every nosepoke on the active or inactive lever. 
During the extinction (sessions 28 and 34) caffeine was available only for coc+caff 
group. 
 
 
 
  
 
40 
 
41 
 
Figure 3 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 Number of infusions during cocaine/caffeine self administration and 
during extinction (1
st–38th session). Results are expressed as mean±SEM of infusions 
earned by each group (coc+caff; coc and caff). # P < 0.05 coc+caff group vs the 
corresponding infusion of caff group; + P < 0.05 coc group vs the corresponding 
infusion of caff group; ° P < 0.05 coc+caff group vs the 15
th SA session; ^ P < 0.05 coc 
group vs the 15
th SA session; * P < 0.05 coc+caff group vs the corresponding infusion 
of coc group. 
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Figure 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 Maximal number of responses (breaking point) completed for the last drug 
infusion under the PR 3-4 schedule of reinforcement.  Results are expressed as 
mean±SEM of nosepokes emitted by each group (coc+caff; coc and caff). # P < 0.05 
coc+caff group vs caff group; + P < 0.05 coc group vs caff group; * P < 0.05 coc+caff 
group vs coc group.  
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